Carolinas Wealth Consulting’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-339
Closed -$27.4K 356
2025
Q1
$27.4K Buy
339
+4
+1% +$344 0.01% 419
2024
Q4
$26.1K Sell
335
-15
-4% -$1.27K 0.01% 442
2024
Q3
$32.8K Buy
350
+15
+4% +$1.26K 0.01% 419
2024
Q2
$26K Sell
335
-129
-28% -$10.5K 0.01% 450
2024
Q1
$42.2K Buy
464
+5
+1% +$416 0.01% 400
2023
Q4
$35.5K Sell
459
-10
-2% -$700 0.01% 381
2023
Q3
$31.2K Sell
469
-202
-30% -$14.7K 0.01% 370
2023
Q2
$54.5K Buy
671
+200
+42% +$16K 0.01% 332
2023
Q1
$38.6K Buy
+471
New +$33.6K 0.01% 398

Other funds holding GEHC

Carolinas Wealth Consulting's GEHC Position: Q2 2025 in Review

Carolinas Wealth Consulting sold out of GE HealthCare (GEHC) in Q2 2025, closing a stake of 339 shares — an estimated $27.4K sold.

Carolinas Wealth Consulting first reported a position in GEHC in Q1 2023 and held it in 9 quarters. The position peaked at $54.5K in Q2 2023. 1,313 funds tracked by Wall St. Rank hold GEHC as of Q2 2025.

  • Carolinas Wealth Consulting reported no remaining GE HealthCare position as of Q2 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 339 GE HealthCare shares in Q2 2025, an estimated $27.4K.
  • Carolinas Wealth Consulting first reported a position in GE HealthCare in Q1 2023 and held it in 9 quarters.
  • Carolinas Wealth Consulting's GE HealthCare position peaked at $54.5K in Q2 2023.
  • 1,313 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.